This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
5 Dogs of the Dow for 2020
by Tirthankar Chakraborty
It may be all bark and no bite for Dogs of the Dow in 2019. But 2020 holds promise for them.
3M (MMM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $178.47, marking a +1.77% move from the previous day.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $169.88, marking a -0.51% move from the previous day.
3M to Divest Drug Delivery Business to Altaris Capital Unit
by Zacks Equity Research
The divestment of 3M's (MMM) drug delivery business will enable the company to focus more on core health care business. This will also lead to a gain of 45 cents to 50 cents per share.
3M (MMM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $168.74, moving +0.64% from the previous trading session.
Stock Market News for Dec 11, 2019
by Zacks Equity Research
U.S. stocks closed lower on Tuesday amid investors??? concern over a partial trade deal as the dateline for fresh U.S. tariff on China will end by this week end.
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
Top Stock Reports for Toyota, CVS Health & 3M
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor (TM), CVS Health (CVS) and 3M (MMM).
3 Orthodontic Stocks to Keep an Eye On
by Sriparna Ghosal
Growth in the orthodontics market has been primarily led by rising focus of vendors on emerging markets, such as Asia-Pacific and LAMEA.
Impressive Near-Term Outlook for Medical Instruments Industry
by Urmimala Biswas
Growing medical awareness and economic prosperity enhance the uptake of medical instruments in the emerging economies.
Stock Market News for Oct 25, 2019
by Zacks Equity Research
Mostly positive earnings results on Thursday helped the S&P 500 and the Nasdaq end in the green.
Eurozone Fears, CAT, MSFT & TSLA Earnings & Buy Callaway Stock - Free Lunch
by Benjamin Rains
New worrisome Eurozone economic data might put more pressure on the U.S. Fed. Quarterly earnings results from Caterpillar, Tesla, Microsoft, and others. And why Callaway Golf (ELY) is a Zack Ranks #1 (Strong Buy) stock - Free Lunch
3M (MMM) Beats Q3 Earnings Estimates, Lowers '19 Projections
by Zacks Equity Research
3M's (MMM) third-quarter 2019 results are affected by forex woes, divestitures and weak organic sales, partially offset by growth in operating margin. It lowers 2019 projections.
3M (MMM) Q3 Earnings Beat Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 4.45% and -1.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Is the Earnings Picture Good or Mixed?
by Sheraz Mian
With one third of Q3 results already in, we take stock of how good or otherwise this reporting cycle has been thus far.
Can Weak End Markets, Forex Woes Hurt 3M (MMM) in 3Q Earnings?
by Zacks Equity Research
3M's (MMM) third-quarter 2019 results are expected to reflect the impact of weak automotive and electronics end markets, forex woes, soft China operations, and high restructuring and tax expenses.
Boeing, Caterpillar, 3M, Microsoft and Twitter are part of Zacks Earnings Preview
by Zacks Equity Research
Boeing, Caterpillar, 3M, Microsoft and Twitter are part of Zacks Earnings Preview
Are Q3 2019 Earnings Results Really That Good?
by Sheraz Mian
With results from almost 15% of S&P 500 members already out, we have a fairly representative sample to judge the Q3 earnings season. The market appears to like the results. But are the results really are that good?
Earnings Preview: 3M (MMM) Q3 Earnings Expected to Decline
by Zacks Equity Research
3M (MMM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3M (MMM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $162.98 in the latest trading session, marking a +1.54% move from the prior day.
Reasons Why Investors Should Avoid 3M (MMM) Stock for Now
by Zacks Equity Research
3M (MMM) suffers from weakness in organic sales, high costs of sales, forex woes and high debts. Fall in cash flow generation is also concerning.
3M Closes Acelity Buyout, Boosts Medical Solutions Business
by Zacks Equity Research
3M's (MMM) Acelity buyout will likely be beneficial for the medical solutions business under the Health Care segment.
Stock Market News For Oct 8, 2019
by Zacks Equity Research
Stocks closed lower on Monday as optimism related to a trade deal between the United States and China faded.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $153.52, marking a -1.48% move from the previous day.
United Technologies Set to Benefit From Strong End Markets
by Zacks Equity Research
Strong commercial aftermarket and military businesses coupled with the acquisition of Rockwell Collins are expected to drive United Technologies' (UTX) growth.